|
KURA Kura Oncology Inc 1422143 |
| Balance Sheet |
|
Current Assets
|
$559,439,000.00 |
|
Assets
|
$587,791,000.00 |
|
Current Liabilities
|
$118,193,000.00 |
|
Liabilities
|
$539,360,000.00 |
|
Equity
|
$48,431,000.00 |
|
Shares Out
|
88954000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-148,403,000.00 |
|
Investing Cash Flow
|
$67,978,000.00 |
| Market Analysis |
Market Cap
|
$1,041,651,340.00 |
|
Price
|
$11.73 |
|
BVPS
|
0.54 |
|
PB
|
21.69 |
|
EPS
|
-0.77 |
|
PS
|
12.48 |
|
FCF
|
$-149,187,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.92 |
|
|
2026-05-12 |
-0.83 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.75 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.85 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KURA documents filed with the SEC.
KURA Filings
Clear
